H. LUNDBECK A/S
Equibles does not estimate personal net worth.
Johan has spoken on 1 earnings call across 1 company, most recently for H. LUNDBECK A/S on August 19, 2026. H. LUNDBECK A/S is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Before turning to some of the more details on the progress of the portfolio I want to recognize our leadership transition in R&D. As announced in June Upon my retirement, Tarek Samad will step in as the executive vice president and head of R&D position as of 1st of September.”
H. LUNDBECK A/S
Transcript header (unverified)
H. LUNDBECK A/S
Drug Manufacturers - Specialty & Generic · Healthcare
Get Visual - Lundbeck Financial statements for the first six months of 2026
H. LUNDBECK A/S
